Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

International patent covers AHP's new antidiabetic agents

Dec. 30, 1999

GelTex and Sankyo finalize agreements for CholestaGel and second-generation product

Dec. 30, 1999

Biopure expands phase III Hemopure clinical trial into Canada

Dec. 30, 1999

Genome Therapeutics initiates osteoporosis genomics alliance with Wyeth-Ayerst

Dec. 29, 1999

SB designs new series of cathepsin K inhibitors

Dec. 28, 1999

Pfizer decides future focus of SERM program

Dec. 28, 1999

Inhale receives U.S. patent protection for pulmonary insulin

Dec. 28, 1999

Vitronectin receptor antagonists for bone disorders codeveloped at HMR and Genentech

Dec. 27, 1999

WF-00144: novel bioactive compound for diabetes

Dec. 27, 1999

FDA approves depot form of Genentech's GH, efficacy of other formulations in increasing spine BMD

Dec. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...